Logo

GOCO

GoHealth, Inc.

GOCO

GoHealth, Inc. • NASDAQ
$3.00 ▲ 2.39% (+0.07)
Market Cap $86.14 M
52w High $21.00
52w Low $2.17
Dividend Yield 0%
P/E -0.18
Volume 26.47K
Outstanding Shares 28.71M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $34.186M ▼ $302.008M ▲ $-165.846M ▼ -485.128% ▼ $-13.52 ▼ $-262.62M ▼
Q2-2025 $94.048M ▼ $161.024M ▼ $-54.277M ▼ -57.712% ▼ $-5.1 ▼ $-73.2M ▼
Q1-2025 $220.972M ▼ $190.789M ▼ $-4.408M ▼ -1.995% ▼ $-0.52 ▼ $33.747M ▼
Q4-2024 $389.132M ▲ $256.629M ▲ $25.509M ▲ 6.555% ▲ $2.42 ▲ $105.027M ▲
Q3-2024 $118.292M $137.45M $6.775M 5.727% $0.58 $60.86M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $32.076M ▼ $1.03B ▼ $1.037B ▲ $68.17M ▼
Q2-2025 $35.59M ▲ $1.311B ▼ $977.078M ▲ $246.665M ▼
Q1-2025 $22.153M ▼ $1.382B ▼ $931.063M ▼ $295.547M ▲
Q4-2024 $40.921M ▲ $1.488B ▲ $1.03B ▲ $294.801M ▲
Q3-2024 $35.527M $1.341B $943.871M $264.063M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-165.846M ▼ $-32.22M ▲ $-2.371M ▲ $30.989M ▼ $-3.514M ▼ $-34.591M ▲
Q2-2025 $-115.989M ▼ $-37.817M ▼ $-2.829M ▲ $53.863M ▲ $13.437M ▲ $-40.646M ▼
Q1-2025 $-9.786M ▼ $-12.405M ▼ $-3.048M ▼ $-3.196M ▲ $-18.768M ▼ $-15.453M ▼
Q4-2024 $57.975M ▲ $14.604M ▲ $-2.218M ▼ $-6.969M ▼ $5.394M ▼ $12.386M ▲
Q3-2024 $-30.082M $-12.227M $13.283M $20.327M $21.403M $-16.48M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Agency Revenue
Agency Revenue
 $0 ▲$0 ▲$80.00M ▲$30.00M ▼
Medicare Revenue
Medicare Revenue
 $0 ▲$0 ▲$90.00M ▲$30.00M ▼
Product and Service Other
Product and Service Other
 $0 ▲$0 ▲$10.00M ▲$10.00M ▲
Commission
Commission
 $200.00M ▲$170.00M ▼$0 ▼$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has stabilized after a sharp drop a few years ago and has been slowly climbing again, though it is still below the early post‑IPO peak. The business generates strong gross margins, which means the core service is economically attractive, but high operating expenses have kept reported profits negative most years. Losses have narrowed steadily, with operating results now hovering close to break‑even and net losses much smaller than before. In simple terms, the income statement tells a story of a company that has moved from heavy losses toward a more disciplined, almost breakeven profile, but that is not yet consistently profitable and remains sensitive to cost control and revenue swings.

Balance Sheet

Balance Sheet The balance sheet shows a company with a modest asset base, a limited cash cushion, and a meaningful amount of debt relative to its equity. Shareholders’ equity has been squeezed over time, though it has started to recover slightly more recently, suggesting some repair of the capital structure. Debt levels are not extreme but leave less room for major missteps, especially given thin profitability. Overall, the balance sheet looks adequate but not conservative: there is some leverage, a relatively narrow equity buffer, and a need for continued discipline around liquidity and debt management.

Cash Flow

Cash Flow Cash flow has improved compared with the early years as a public company. The business used to burn cash from operations, but more recently it has moved closer to cash break‑even, with some years generating cash and others using a small amount. Free cash flow has followed the same pattern, and capital spending remains low, reflecting a relatively asset‑light, technology‑driven model. The main message from the cash flow statement is that the worst of the cash burn appears to be behind the company, but it has not yet proven it can reliably produce steady, positive cash generation through different market conditions.

Competitive Edge

Competitive Edge GoHealth operates in a crowded Medicare insurance brokerage market with several well‑known digital and telesales competitors. Its edge comes from combining a large agent workforce with a sophisticated technology stack that tries to make plan selection simpler and more tailored for seniors. The pivot from chasing volume to focusing on member retention, quality of enrollments, and deeper post‑sale support is designed to align more closely with what insurance carriers value and to reduce churn. That said, the company still faces tough competition, regulatory complexity in Medicare Advantage, and dependence on carrier relationships and compensation structures, all of which can pressure margins and growth if market conditions turn.

Innovation and R&D

Innovation and R&D Innovation is a clear focus. GoHealth has built proprietary tools such as its Encompass platform, PlanFit matching engine, and PlanGPT AI assistant, all aimed at helping agents quickly sort through complex Medicare options and provide more personalized recommendations. It also uses internal AI tools to score leads and route calls, trying to raise conversion and satisfaction. Beyond technology, the firm is experimenting with new service layers like TeleCare support teams and a greater focus on Special Needs Plans and member add‑on services. The key question is whether these innovations can translate into meaningfully better retention, lower acquisition costs, and stronger carrier partnerships over time, turning tech advantage into durable economics.

Summary

GoHealth looks like a company in transition from high‑growth, high‑burn behavior toward a more disciplined, efficiency‑driven model. Revenues have stabilized and are slowly recovering, margins have improved, and cash burn has narrowed, but sustained profitability and robust cash generation are not yet firmly established. The balance sheet is serviceable but not overly strong, with limited cash and moderate leverage that make ongoing execution important. Competitively, GoHealth leans on its hybrid of advanced technology and human agents, plus a retention‑first strategy in a complex Medicare Advantage landscape. Its innovation efforts in AI and member support are promising and differentiated, but the long‑term success of the story depends on converting those capabilities into consistently better economics while navigating regulatory shifts, carrier dynamics, and intense competition.

NEWS

November 17, 2025 · 9:52 AM UTC

Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 2025 Q3

Read more

November 11, 2025 · 9:00 AM UTC

GoHealth to Announce Third Quarter 2025 Results on November 13, 2025

Read more

October 14, 2025 · 2:30 PM UTC

GoHealth Helps Medicare Consumers Navigate Another Disruptive Annual Enrollment Period (AEP) With Personalized Guidance

Read more

September 29, 2025 · 9:16 AM UTC

Go Metals Initiates Metallurgical Testing at KM98 Fe-Ti-V Project

Read more